期刊文献+

白细胞介素-4和白细胞介素-13基因多态性对哮喘患儿IgE表达的影响 被引量:7

The Influence of IL-4 and IL-13 Gene Polymorphism on Ig E Level in Children with Asthma
下载PDF
导出
摘要 目的:探讨白细胞介素-4(IL-4)和白细胞介素-13(IL-13)基因多态性对哮喘患儿Ig E表达的影响。方法:采用聚合酶链式反应(PCR)检测173例哮喘患儿及56例健康儿童的IL-4和IL-13基因限制性长度片段,及不同基因型患儿Ig E的表达水平。结果:哮喘患儿IL-4基因-589位点基因多态性和等位基因与健康对照儿童比较差异无统计学意义(P>0.05)。哮喘患儿IL-13基因+1923位点基因多态性和等位基因与健康对照儿童比较差异有统计学意义(P<0.01)。IL-4基因-589和IL-13基因+1923位点T等位基因患儿Ig E水平显著高于C等位基因患儿(P<0.01)。结论:哮喘患儿IL-13基因多态性与健康儿童不同,IL-4基因-589位点和IL-13基因+1923T等位基因是导致哮喘患儿Ig E水平升高的可能原因。 Objective: To study the influence of interleukin-4( IL-4) and interleukin-13( IL-13) gene polymorphism on Ig E level in asthma children. Methods: PCR was applied to detect the restriction fragment length of IL-4 gene and IL-13 gene in 173 asthma children and 56 healthy children and the Ig E expression levels of different genotypes. Results: The gene polymorphism and alleles of IL-4-589 had no significant difference between two control( P〉0.05). The gene polymorphism and alleles of IL-13+1923 in asthma children were significantly different between two groups( P〈0.01). The Ig E level in asthma children with T allele of IL-13+1923 gene and IL-4-589 were significantly higher than those in C allele( P〈0.01). Conclusion: The IL-13 gene polymorphism was different from healthy control and the T allele of IL-4-589 and IL-13+1923 may play an important role on the increase of Ig E in asthma children.
作者 王红利
出处 《儿科药学杂志》 CAS 2016年第4期7-9,共3页 Journal of Pediatric Pharmacy
关键词 儿童 哮喘 白细胞介素4 白细胞介素13 基因多态性 children asthma interleukin-4 interleukin-13 gene polymorphism
  • 相关文献

参考文献13

  • 1SONNENSCHEIN-VAN DER VOORT A M, ARENDS L R, DE JONGSTE J C, et al. Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children [J]. J Allergy Clin Immunol, 2014, 133(5) : 1317-1329.
  • 2SORDILLO J E, KELLY R, BUNYAVANICH S, et al. Genome- wide expression profiles identify potential targets for gene- environment interactions in asthma severity [ J ]. J Allergy Clin Immunol, 2015, pii: S0091-6749 (15) 00341-3.
  • 3BARLOW J L, PEEL S, FOX J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells ) and airway contraction [ J ]. J Allergy Clin Immunol, 2013, 132(4): 933-941.
  • 4AL-MUHSEN S, VAZQUEZ-TELLO A, ALZAABI A, et al. IL-4 receptor alpha single-nucleotide polymorphisms rs1805010 and rs1801275 are associated with increased risk of asthma in a Saudi Arabian population [J]. Ann Thorac Med, 2014, 9(2): 81-86.
  • 5FAHY J V. Type 2 inflammation in asthma-present in most, absent in many [J]. Nat Rev Immunol, 2015, 15(1) : 57-65.
  • 6KASAIAN M T, MARQUETYE K, FISH S, eta!. An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperrespon- siveness, and IgE production in mice [ J]. Am J Respir Cell Mol Biol, 2013, 49(1): 37-46.
  • 7杨慧,向平超.支气管哮喘全球倡议(2012更新版)简介[J].中国医学前沿杂志(电子版),2013,5(8):25-29. 被引量:22
  • 8WENZEL S, MING J, HAMILTON J, et al. Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/ REGN668) inhibits key biomarkers in asthma [ J ]. EuropeanRespiratory Journal, 2013, 42(Suppl 57): 3539.
  • 9ZHU S, CHAN-YEUNG M, BECKER A B, et al. Polymor- phisms of the IL-4, TNF-ct, and Fc ot RI ~ Genes and the Risk of Allergic Disorders in At-risk Infants [ J ]. Am J Respir Crit Care Med, 2000, 161(5): 1655-1659.
  • 10KAMALI-SARVESTANI E, GHAYOMI M A, NEKOEE A. Association of TNF-alpha- 308 G/A and IL-4- 589 C/T gene promoter polymorphisms with asthma susceptibility in the south of Iran [J~. J Investig Allergol Clin Immtmol, 2007, 17(6) : 361-366.

二级参考文献34

  • 1Noguchi E, Shibasaki M, Arinami T, et al.Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy, 1998, 28: 44 9-453.
  • 2Hijazi Z, Haider MZ.Interleukin-4 gene promoter polymorphism a nd asthma in Kuwaiti Arabs. Int Arch Allergy Immunol, 2000, 122: 190-194.
  • 3Burchard EG, Silverman EK, Rosenwasser LJ, et al.Association be tween a sequence variant in the IL-4 gene promoter and FEV1 in asthma.Am J Reap ir Crit Care Med, 1999, 160: 919-922.
  • 4Lazarus M, Hajeer A, Tu rner D, et al.Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.J Rheumatol, 1997, 74: 2314-2317.
  • 5Mok CC, Lanchbury JS, Chan DW, et al.Interleukin-10 promoter polymorp hisms in Southern Chinese patients with system lupus erythematosus.Arthritis Rh eum, 1998, 41: P1090-1095.
  • 6Sanford AJ, Chagani T, Zhu S, et al.Polymorphisms in the IL-4, IL-4R A and Fc ε RI β genes and asthma severity .J Allergy Clin Immunol, 2000, 106: 135-140.
  • 7Zhu S, Chan YM, Becker AB, et al.Polymorphisms of the IL-4, TNF-α a nd Fc ε RI β genes and the risks of allergic disorders in at-risk infants.Am J Respir Crit Care, 2000, 161: P1655-1659.
  • 8Rosenwasser LJ,Borish L.Genetics of atopy and asthma: the rationale be hind promoter-based candidate gene studies(IL-4 and IL-10).Am J Respir Crit C are Med, 1997, 156: S152-155.
  • 9Crawley E, Kay R, Sillibourne J, et al .Polymorphic haplotypes of the interleukin-10 5′flanking region determine vari able interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.Arthritis Rheuma, 1999, 42: 1101-1108.
  • 10Coffma RL, Lebman DA, Rothma P.Mechanism and regulation of immunoglobulin isotyp e switching.Adv Immunol,1993, 54: 229-270.

共引文献79

同被引文献57

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部